AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

NCT00535353 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: irinotecan hydrochloride
DRUG: olaparib

Sponsor

NCIC Clinical Trials Group

Collaborators

[object Object]